About ScreenCancer UK
ScreenCancer UK strive to increase and develop knowledge and technology in Cancer Screening. We focus on a quality, cost effective and confidential service to all our customers using innovative screening technology and highly trained professionals all our cancer screening services.
In addition to support from the international team in ScreenCancer, we also gain access to valuable international dermatology expertise through the medical board of Novel Diagnostics ( the mother company of ScreenCancer). Dr. Kurt Ayerst (UK) and Dr. David Swanson (USA) is supporting our service with their wide expertise in dermatology and dermoscopy.
The ScreenCancer team
We proudly deliver our service using highly experience dermatology specialists and dermatology nursesMeet our team
The Mole Navigator system
Our service uses latest image technology to view beneath the skin to identify and display graphically the separate components of the skin up to 2mm depthRead more
If you have any questions or comments, do not hesitate to contact usContact ScreenCancer UK
Our customers are our priority
At ScreenCancer we pride ourselves on a small team of highly qualified professionals.
We ensure we consider the specific needs of our customers, by delivering our service in a prompt, confidential, dignified manner adapting to the needs of diverse communities.
ScreenCancer are proactive and pragmatic in their approach and are passionate and driven to raise awareness of skin cancer through educating self-checking, prevention and early detection to the UK with our service.
ScreenCancer UK was established in 2015 as a part of ScreenCancer AS in Norway. The Norwegian mother company was founded in Bergen, Norway in 2007 with the vison of saving lives through Cancer screening. The company is now represented outside Norway within the UK, Sweden and US, focusing on the Mole Scanning Service.
If you have any questions please contact us!